BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25879692)

  • 1. Titration of biologically active amyloid-β seeds in a transgenic mouse model of Alzheimer's disease.
    Morales R; Bravo-Alegria J; Duran-Aniotz C; Soto C
    Sci Rep; 2015 Mar; 5():9349. PubMed ID: 25879692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of amyloid-β deposits from serially transmitted, histologically silent, Aβ seeds issued from human brains.
    Hérard AS; Petit F; Gary C; Guillermier M; Boluda S; Garin CM; ; Lam S; Dhenain M
    Acta Neuropathol Commun; 2020 Nov; 8(1):205. PubMed ID: 33250056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
    Bi Oh S; Suh N; Kim I; Lee JY
    Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altering Brain Amyloidosis by Intra-Lingual and Extra-Nasal Exposure of Aβ Aggregates.
    Gamez N; Bravo-Alegria J; Huang Y; Perez-Urrutia N; Dongarwar D; Soto C; Morales R
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Izco M; Martínez P; Corrales A; Fandos N; García S; Insua D; Montañes M; Pérez-Grijalba V; Rueda N; Vidal V; Martínez-Cué C; Pesini P; Sarasa M
    Neuroscience; 2014 Mar; 263():269-79. PubMed ID: 24447596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of Aβ deposition in the nasal cavity with the formation of senile plaques in the brain of a transgenic mouse model of Alzheimer's disease.
    Kameshima N; Nanjou T; Fukuhara T; Yanagisawa D; Tooyama I
    Neurosci Lett; 2012 Apr; 513(2):166-9. PubMed ID: 22343315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infusion of blood from mice displaying cerebral amyloidosis accelerates amyloid pathology in animal models of Alzheimer's disease.
    Morales R; Duran-Aniotz C; Bravo-Alegria J; Estrada LD; Shahnawaz M; Hu PP; Kramm C; Morales-Scheihing D; Urayama A; Soto C
    Acta Neuropathol Commun; 2020 Dec; 8(1):213. PubMed ID: 33287898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
    Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
    Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of Abeta accumulation in the Tg2576 animal model of Alzheimer's disease after oral administration of the phosphatidyl-inositol kinase inhibitor wortmannin.
    Haugabook SJ; Le T; Yager D; Zenk B; Healy BM; Eckman EA; Prada C; Younkin L; Murphy P; Pinnix I; Onstead L; Sambamurti K; Golde TE; Dickson D; Younkin SG; Eckman CB
    FASEB J; 2001 Jan; 15(1):16-18. PubMed ID: 11099491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission of cerebral amyloid pathology by peripheral administration of misfolded Aβ aggregates.
    Morales R; Bravo-Alegria J; Moreno-Gonzalez I; Duran-Aniotz C; Gamez N; Edwards Iii G; Soto C
    Mol Psychiatry; 2021 Oct; 26(10):5690-5701. PubMed ID: 34002023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pathobiology of β-amyloid and the unique susceptibility of humans to Alzheimer's disease.
    Rosen RF; Tomidokoro Y; Farberg AS; Dooyema J; Ciliax B; Preuss TM; Neubert TA; Ghiso JA; LeVine H; Walker LC
    Neurobiol Aging; 2016 Aug; 44():185-196. PubMed ID: 27318146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA).
    Burwinkel M; Lutzenberger M; Heppner FL; Schulz-Schaeffer W; Baier M
    Acta Neuropathol Commun; 2018 Mar; 6(1):23. PubMed ID: 29506560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer's disease animal model.
    Cho HJ; Son SM; Jin SM; Hong HS; Shin DH; Kim SJ; Huh K; Mook-Jung I
    FASEB J; 2009 Aug; 23(8):2639-49. PubMed ID: 19332646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer's disease.
    Sung S; Yao Y; Uryu K; Yang H; Lee VM; Trojanowski JQ; Praticò D
    FASEB J; 2004 Feb; 18(2):323-5. PubMed ID: 14656990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited expression of heparan sulphate proteoglycans associated with Aβ deposits in the APPswe/PS1dE9 mouse model for Alzheimer's disease.
    Timmer NM; Herbert MK; Kleinovink JW; Kiliaan AJ; De Waal RM; Verbeek MM
    Neuropathol Appl Neurobiol; 2010 Oct; 36(6):478-86. PubMed ID: 20831743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly potent intracellular membrane-associated Aβ seeds.
    Marzesco AM; Flötenmeyer M; Bühler A; Obermüller U; Staufenbiel M; Jucker M; Baumann F
    Sci Rep; 2016 Jun; 6():28125. PubMed ID: 27311744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairments in brain-to-blood transport of amyloid-β and reabsorption of cerebrospinal fluid in an animal model of Alzheimer's disease are reversed by antisense directed against amyloid-β protein precursor.
    Banks WA; Kumar VB; Farr SA; Nakaoke R; Robinson SM; Morley JE
    J Alzheimers Dis; 2011; 23(4):599-605. PubMed ID: 21098986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-β in the Cerebrospinal Fluid of APP Transgenic Mice Does not Show Prion-like Properties.
    Skachokova Z; Sprenger F; Breu K; Abramowski D; Clavaguera F; Hench J; Staufenbiel M; Tolnay M; Winkler DT
    Curr Alzheimer Res; 2015; 12(9):886-91. PubMed ID: 26159190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aβ seeding potency peaks in the early stages of cerebral β-amyloidosis.
    Ye L; Rasmussen J; Kaeser SA; Marzesco AM; Obermüller U; Mahler J; Schelle J; Odenthal J; Krüger C; Fritschi SK; Walker LC; Staufenbiel M; Baumann F; Jucker M
    EMBO Rep; 2017 Sep; 18(9):1536-1544. PubMed ID: 28701326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model.
    Wang Q; Xu Y; Chen JC; Qin YY; Liu M; Liu Y; Xie MJ; Yu ZY; Zhu Z; Wang W
    Brain Res; 2012 Jun; 1459():15-26. PubMed ID: 22560596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.